 
                                Ahmar U. Zaidi, MD (Dr. Z)
@drzsicklecell
#sicklecell advocate|blood doc for kids|podcaster|💊 development for sickle cell disease|@tedx speaker|views mine only
ID: 2423747018
02-04-2014 12:41:59
5,5K Tweet
5,5K Takipçi
4,4K Takip Edilen
 
        Lack of access to fertility preservation prior to BMT was my motivation for wanting to tackle this first. Thank you to my partners at Be the Match for a dream realized. I've almost double my internal impact goal @LydiaPecker Alexandra Power-Hays, MD Ahmar U. Zaidi, MD (Dr. Z) NIH NHLBI
 
                        
                    
                    
                    
                 
         
         
        Absolutely absurd Saturday Night Live - SNL Kenan Thompson #SickleCell is not a joke and this type of racist nonsense perpetuates the the problem. I am beyond words
 
         
        Such important and timely work from the phenomenal Satoko Ito, MD PhD George Goshua, MD MSc at Goshua Lab Yale School of Medicine YaleHematology !!! Hem-Onc Fellows Network Hematology & Oncology Women Physicians Group—HOWPG Ahmar U. Zaidi, MD (Dr. Z)
 
         
         
         
        We're thrilled to share the FDA has approved vorasidenib, representing a significant step forward for patients. Congrats to Servier Pharmaceuticals and the Agios team for their early discovery and development efforts. Read more: investor.agios.com/news-releases/…
 
                        
                    
                    
                    
                 
        Awareness is good but we need so much action. Akshat Jain MD MPH FRCP Don Magezi Steven Byamugisha II Wilma National Organization for Rare Disorders (NORD) Raising Hope International Friends Uganda Sickle Cell Rescue Foundation @ddanielroy Ahmar U. Zaidi, MD (Dr. Z) Dr Dexter(CEO-SickleCellAwarenessFoundation) Audreysicklecellfoundation Shematologist, MD Blood Diseases & Disorders Education Program SCDAA Dr. Eve Nakato
 
         
         
         
         
        The hospital-at-home movement is in its early days. Lots of potential using multimodal #AI remote monitoring and validation via randomized trials washingtonpost.com/health/2024/11… by Fenit Nirappil w/ Jay Pandit nature.com/articles/s4174…
 
                        
                    
                    
                    
                 
         
         
                         
                         
                         
                         
                         
                        